Funded Biotech startups in Maryland
13 biotech startups in Maryland have filed a Form D with the SEC and together report $598.8M raised. Sensei Biotherapeutics has the largest latest round, at $348.9M. Amounts are as reported on the filing, not estimates.
Updated Sep 30, 2026
- Companies
- 13
- Total raised
- $598.8M
- Filings
- 19
- Median round
- $4.2M
- Cities
- 7
CompanyCityLast filingLatest round
KaigeneAntibody drugs that degrade disease-causing autoantibodies
Rockville
Sep 30, 2026
$55.0M
TheradaptiveImplant-binding proteins for bone and tissue repair
Frederick
Jul 21, 2026
$36.2M
GeorgiamuneImmune-reprogramming antibodies for cancer and autoimmunity
Gaithersburg
Jul 16, 2026
$92.7M
OS TherapiesHER2-targeted immunotherapy for osteosarcoma
Grasonville
Jun 30, 2026
$1.6M
Shuttle PharmaceuticalsRadiation-sensitizing drug for glioblastoma
Gaithersburg
Apr 30, 2026
$10.0M
RllOral drug that blocks cancer cell DNA repair and growth
Lutherville
Apr 6, 2026
$2.0M
Iyuda TherapeuticsOff-the-shelf donor cell therapy for cancer
Owings Mills
Mar 23, 2026
$600K
Pearl DiagnosticsUrine tests for invasive fungal lung infections
Baltimore
Mar 19, 2026
$11.2M
Sensei BiotherapeuticsTargeted drug for endometrial and breast cancer
Rockville
Feb 17, 2026
$348.9M
Elixirgen TherapeuticsmRNA therapies for rare diseases and cancer
Baltimore
Oct 30, 2025
$4.0M
GliknikFc fusion biologics for autoimmune disease and cancer
Baltimore
Aug 15, 2025
$11.0M
Zero Point Five TherapeuticsFlubendazole treatment for intestinal worm infections
Baltimore
Apr 2, 2025
$4.3M
Infinity BioAntibody profiling against large antigen libraries
Baltimore
Feb 18, 2025
$2.0M
All 13 companies · most recent filing first
Most recent filings
13All 13 companies · most recent filing first